Table 1 Binding affinity of C05 variants against hemagglutinins from different influenza strains.

From: In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity

K d in nM

Residue 190

VVSAGW (WT)

VPGSGW

VVSSGW

VTGSGW

A/Solomon Islands/3/2006 (H1N1)

D

91.4±0.9

15.0±0.2

4.6±0.6

115.8±1.9

A/New Caledonia/20/1999 (H1N1)

N

6.3±0.1

0.6±0.0

2.9±0.1

1.1±0.2

A/Beijing/262/1995 (H1N1)

V

23.1±0.6

12.6±0.7

259.3±2.8

182.3±0.5

A/WSN/1933 (H1N1)

E

169.4±1.0

719.6±2.9

727.7±20.5

1,539±42

A/Japan/305/1957 (H2N2)

E

1,701±46

>5,000

>5,000

>5,000

A/Hong Kong/1/1968 (H3N2)

E

327.8±12.0

958.8±45.6

1,100±94

1,860±83

A/Panama/2007/1999 (H3N2)

D

926.3±12.1

1,306±12

1,290±71

4,335±207

A/Perth/16/2009 (H3N2)*

D

23.4±0.1

43.6±1.0

43.7±0.5

125.1±1.2

  1. *C05 is able to make additional interaction with A/Perth/16/2009 (H3N2) via CDR H1 (ref. 21).